Trial Profile

A phase 1/2 study of JadiCell in treatment of Chronic Obstructive Pulmonary Disease (COPD)

Status: Planning

Phase of Trial: Phase I/II

Latest Information Update: 27 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Allogeneic umbilical cord mesenchymal stem cells-Therapeutic Solutions International (Primary)
Indications Chronic obstructive pulmonary disease
Focus Adverse reactions; Therapeutic Use

Most Recent Events

27 May 2022 New trial record
23 May 2022 According to a Therapeutic Solutions International media release, the company has received an Investigational New Drug application number 28508 from the United States Food and Drug Administration for initiation of this study.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com